A new name for the AO group
Santiago Marco’s research group at IBEC has changed its name and will now be known as the Signal and Information Processing for Sensing Systems group.
Santiago Marco’s research group at IBEC has changed its name and will now be known as the Signal and Information Processing for Sensing Systems group.
From 1st February 2013 onwards, the Nanotechnology Platform at the Parc Científic Barcelona (PCB), which for many years has helped users develop innovative cutting-edge research incorporating micro- and nanotechnologies in a wide variety of fields, will transfer to the ownership and management of IBEC.
IBEC has signed a Memorandum of Understanding with the Barcelona Macula Foundation to jointly promote their respective activities in the context of biomedicine.
Before Christmas, IBEC’s associate director Josep Samitier was a panel member and speaker at a session of the seminar series ‘Nous horitzons per a l’economia metropolitana’ entitled ‘La salut, un gran potencial’. The seminar series seeks to strengthen public policies and private actions in those sectors, such as health, which have the ability to generate or export business successfully in spite of the prolonged financial crisis.
An IBEC group leader was elected as president of the Sociedad Española de Ingeniería Biomédica (SEIB) at its annual meeting (CASEIB) in San Sebastián last week.
Twenty members of the general public had their minds blown this morning at IBEC’s Open Doors Day, which was entitled ‘La Bioenginyeria per a Tothom’.Last Tuesday, within the framework of the Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER- BBN), IBEC signed an agreement with pharmaceutical company Ferrer and the universities of Valladolid and the Basque Country to work towards developing a stem cell-based therapy to regenerate the surface of the eye.
Yesterday saw the launch in Madrid of a new NanoMed Spain publication, ‘Hoja por la Innovación en Nanomedicina en España’ (White Paper on Innovation in Nanomedicine in Spain), which diagnoses the country’s R&D&I capacities in the field so far and presents the potential opportunities, challenges and recommendations for the future.